Diagnostic News and Research

RSS

New ESC atlas data highlights disparities in cardiovascular disease mortality

Cardiovascular disease (CVD) remains the most common cause of death across Europe but while CVD mortality rates are generally decreasing, the decline is much less in middle-income than in high-income countries, according to new data from the European Society of Cardiology (ESC) Atlas of Cardiology, published in the European Heart Journal.

27 Aug 2024

EPAM Joins Sapio Sciences Partner Program

...

From Sapio Sciences 27 Aug 2024

MP Biomedicals announces the launch of advanced gastrointestinal diseases diagnostic kits

MP Biomedicals completes its range of in vitro diagnostic tests for infectious diseases with new immunochromatographic-based qualitative rapid tests.The new diagnostic kits by MP Biomedicals leverage cutting-edge technology to deliver precise results, enabling healthcare professionals a rapid and accurate detection of Helicobacter pylori, Salmonella typhi and Vibrio cholerae serogroups O1 and O139.

From MP Biomedicals, LLC 27 Aug 2024

New benchmark: 1 kg of plasmid DNA manufactured

Kaneka Eurogentec sets new benchmark in plasmid DNA manufacturing with the production of 1 kg of plasmid DNA.

From Kaneka Eurogentec S.A 27 Aug 2024

Increased mental health risks in patients with brain aneurysms

Among people who had aneurysms (weakened areas in brain blood vessels), the risk of developing a mental health condition was higher than among peers without an aneurysm.

26 Aug 2024

Exploring early detection of Alzheimer's disease through non-cognitive symptoms

The article presents a thorough examination of Alzheimer's disease (AD), emphasizing early detection as critical due to the disease's progression through stages from normal cognition to mild cognitive impairment (MCI) and eventually dementia.

26 Aug 2024

WHO launches global plan to stop human-to-human transmission of mpox

The World Health Organization (WHO) today launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of mpox through coordinated global, regional, and national efforts.

26 Aug 2024

Children and adolescents experience unique long COVID symptoms

A study characterizes childhood long COVID, revealing distinct symptoms in children and adolescents, highlighting the need for tailored diagnostic approaches.

26 Aug 2024

Gut microbe metabolite found to modulate heart disease risk through β2-adrenergic receptors

Study identifies phenylacetylglutamine (PAGln), a gut microbiome metabolite, as a novel allosteric modulator of β2-adrenergic receptors, offering insights into its role in cardiovascular disease (CVD) risk.

26 Aug 2024

CDC study reveals critical gaps in hantavirus detection across the U.S. due to inconsistent testing standards

Researchers map the prevalence and genotype distribution of hantavirus in the U.S., highlighting significant regional differences and the need for standardized testing

25 Aug 2024

Telehealth mindfulness interventions significantly improve chronic pain outcomes for veterans

Scalable telehealth mindfulness-based interventions (MBIs) effectively improve pain-related function and biopsychosocial outcomes in veterans with chronic pain compared to standard care. The study confirms that low-cost, non-pharmacological treatments like MBIs can be accessible and beneficial via telehealth platforms.

25 Aug 2024

Multiple sclerosis patients less likely to have molecular hallmarks of Alzheimer's disease

People with multiple sclerosis (MS) are far less likely than those without the condition to have the molecular hallmarks of Alzheimer's disease, according to new research from Washington University School of Medicine in St. Louis.

23 Aug 2024

Portable OCT otoscope improves diagnostic capabilities in hearing clinics

In the realm of ear health, accurate diagnosis is crucial for effective treatment, especially when dealing with conditions that can lead to hearing loss.

23 Aug 2024

New $5.8 million grant aims to transform the global landscape of TB research

A $5.8 million grant led by Adrie Steyn, Ph.D., of the University of Alabama at Birmingham and the Africa Health Research Institute, or AHRI, in Durban, South Africa, will provide user-requested infected human lung tissue and analytical services to tuberculosis researchers worldwide.

23 Aug 2024

Innovations in biomarker detection and personalized medicine for prostate cancer

In a recent comprehensive review published in Cyborg Bionic Systems, researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang, along with international collaborators, detail significant advances in the identification and application of biomarkers for prostate cancer (PCa).

23 Aug 2024

Advances in sequencing uncover rare genetic variants in colorectal cancer

Colorectal cancer (CRC) presents a significant health challenge, especially with rare genetic variations complicating treatment.

23 Aug 2024

New AI-driven platform enhances lung cancer tissue analysis

A team of researchers from the University of Cologne's Faculty of Medicine and University Hospital Cologne, led by Dr Yuri Tolkach and Professor Dr Reinhard Büttner, has created a digital pathology platform based on artificial intelligence.

23 Aug 2024

Discovery of TLNRD1 protein could help better understand Cerebral Cavernous Malformations disease

Researchers have discovered a crucial protein, TLNRD1, that could help us better understand and treat Cerebral Cavernous Malformations (CCM) disease.

23 Aug 2024

Defective ZNRF3 gene causes opposing brain sizes and potential tumor risk

A gene called ZNRF3, known to be involved in cancer, also messes with the mind. The human brain relies on two copies of this gene to build a right-sized brain. If one of the copies is defective, the brain will be either too small or too large - known as mirror effect -, leading to various neurological symptoms.

23 Aug 2024

AmoyDx® Pan Lung Cancer PCR Panel approved in Japan as a companion diagnostic for Haiyitan® tablets (gumarontinib)

Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the AmoyDx® Pan Lung Cancer PCR Panel

From Amoy Diagnostics 23 Aug 2024

Diagnostic News and Research

New ESC atlas data highlights disparities in cardiovascular disease mortality

EPAM Joins Sapio Sciences Partner Program

MP Biomedicals announces the launch of advanced gastrointestinal diseases diagnostic kits

New benchmark: 1 kg of plasmid DNA manufactured

Increased mental health risks in patients with brain aneurysms

Exploring early detection of Alzheimer's disease through non-cognitive symptoms

WHO launches global plan to stop human-to-human transmission of mpox

Children and adolescents experience unique long COVID symptoms

Gut microbe metabolite found to modulate heart disease risk through β2-adrenergic receptors

CDC study reveals critical gaps in hantavirus detection across the U.S. due to inconsistent testing standards

Telehealth mindfulness interventions significantly improve chronic pain outcomes for veterans

Multiple sclerosis patients less likely to have molecular hallmarks of Alzheimer's disease

Portable OCT otoscope improves diagnostic capabilities in hearing clinics

New $5.8 million grant aims to transform the global landscape of TB research

Innovations in biomarker detection and personalized medicine for prostate cancer

Advances in sequencing uncover rare genetic variants in colorectal cancer

New AI-driven platform enhances lung cancer tissue analysis

Discovery of TLNRD1 protein could help better understand Cerebral Cavernous Malformations disease

Defective ZNRF3 gene causes opposing brain sizes and potential tumor risk

AmoyDx® Pan Lung Cancer PCR Panel approved in Japan as a companion diagnostic for Haiyitan® tablets (gumarontinib)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News